Stochastic Modeling and Simulation of the p53-MDM2/MDMX Loop
暂无分享,去创建一个
[1] T. Tursz,et al. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells , 1998, Oncogene.
[2] A. Jochemsen,et al. Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53* , 2002, The Journal of Biological Chemistry.
[3] John Jeremy Rice,et al. A plausible model for the digital response of p53 to DNA damage. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[4] John D. Storey,et al. Genome-wide analysis of mRNA translation profiles in Saccharomyces cerevisiae , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] Hong Yang,et al. Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis*♦ , 2004, Journal of Biological Chemistry.
[6] K. Sakaguchi,et al. Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like Kinase , 2000, The Journal of Biological Chemistry.
[7] A. Levine,et al. The P53 pathway: what questions remain to be explored? , 2006, Cell Death and Differentiation.
[8] J. Landers,et al. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. , 1997, Cancer research.
[9] G. Wahl,et al. Gatekeepers of the Guardian: p53 Regulation by Post-Translational Modification, MDM2 and MDMX , 2007 .
[10] G. Mize,et al. Role of two upstream open reading frames in the translational control of oncogene mdm2 , 1999, Oncogene.
[11] Jeremy R Stuart,et al. DNA Damage-induced MDMX Degradation Is Mediated by MDM2* , 2003, Journal of Biological Chemistry.
[12] D. Gillespie. Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .
[13] M. Oren,et al. A functional p53-responsive intronic promoter is contained within the human mdm2 gene. , 1995, Nucleic acids research.
[14] A. Fersht,et al. Molecular mechanism of the interaction between MDM2 and p53. , 2002, Journal of molecular biology.
[15] M. Oren,et al. Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. , 1994, Genes & development.
[16] M. E. Perry,et al. Characterization of the 5' and 3' untranslated regions in murine mdm2 mRNAs. , 2001, Gene.
[17] Guillermina Lozano,et al. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 , 1995, Nature.
[18] K. McLure,et al. How p53 binds DNA as a tetramer , 1998, The EMBO journal.
[19] J. Raser,et al. Noise in Gene Expression: Origins, Consequences, and Control , 2005, Science.
[20] D. Faller,et al. DNA-damaging Aryl Hydrocarbons Induce Mdm2 Expression via p53-independent Post-transcriptional Mechanisms* , 2000, The Journal of Biological Chemistry.
[21] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[22] G. Wahl,et al. Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation , 2004, The EMBO journal.
[23] Yu Pan,et al. MDM2 Promotes Ubiquitination and Degradation of MDMX , 2003, Molecular and Cellular Biology.
[24] R. Ramirez-Solis,et al. mdmx is a negative regulator of p53 activity in vivo. , 2002, Cancer research.
[25] N. Little,et al. Hdmx stabilizes Mdm2 and p53. , 2000, The Journal of biological chemistry.
[26] G. Stark,et al. Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3. , 2006, Cancer research.
[27] A. Arkin,et al. Stochastic mechanisms in gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] A. Levine,et al. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. , 1993, Oncogene.
[29] R. Copeland,et al. Thermodynamics of p53 binding to hdm2(1-126): effects of phosphorylation and p53 peptide length. , 2000, Archives of biochemistry and biophysics.
[30] K. Sneppen,et al. Time delay as a key to apoptosis induction in the p53 network , 2002, cond-mat/0207236.
[31] Muyang Li,et al. A dynamic role of HAUSP in the p53-Mdm2 pathway. , 2004, Molecular cell.
[32] M. Oren. Regulation of the p53 Tumor Suppressor Protein* , 1999, The Journal of Biological Chemistry.
[33] R. Milo,et al. Oscillations and variability in the p53 system , 2006, Molecular systems biology.
[34] Ruedi Aebersold,et al. Gene expression in yeast responding to mating pheromone: Analysis by high-resolution translation state analysis and quantitative proteomics , 2004 .
[35] J C Hewson,et al. Stochastic simulation of transport and chemical kinetics in turbulent CO/H2/N2 flames , 2001 .
[36] Jean-Christophe Marine,et al. Mdmx as an essential regulator of p53 activity. , 2005, Biochemical and biophysical research communications.
[37] G. Wahl,et al. Quantitative analyses reveal the importance of regulated Hdmx degradation for P53 activation , 2007, Proceedings of the National Academy of Sciences.
[38] J. Gregg,et al. Allele-specific Holliday junction formation: a new mechanism of allelic discrimination for SNP scoring. , 2003, Genome research.
[39] A. Jochemsen,et al. MDMX: a novel p53‐binding protein with some functional properties of MDM2. , 1996, The EMBO journal.
[40] Muyang Li,et al. Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2 , 2003, Science.
[41] A. Levine,et al. The p53-mdm-2 autoregulatory feedback loop. , 1993, Genes & development.
[42] K. Shirouzu,et al. MDM2 interacts with MDMX through their RING finger domains , 1999, FEBS letters.
[43] K. Vousden,et al. Coping with stress: multiple ways to activate p53 , 2007, Oncogene.
[44] Hyunggee Kim,et al. Post-transcriptional inactivation of p53 in immortalized murine embryo fibroblast cells , 2001, Oncogene.
[45] K. Helin,et al. Mdm4 (Mdmx) Regulates p53-Induced Growth Arrest and Neuronal Cell Death during Early Embryonic Mouse Development , 2002, Molecular and Cellular Biology.
[46] Andrea Ciliberto,et al. Steady States and Oscillations in the p53/Mdm2 Network , 2005, Cell cycle.
[47] H. Xiao,et al. Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes. , 2000, Carcinogenesis.
[48] H. Dolznig,et al. Isolation of polysome-bound mRNA from solid tissues amenable for RT-PCR and profiling experiments. , 2007, RNA.
[49] N. Sonenberg,et al. 1 Origins and Principles of Translational Control , 2007 .
[50] T Misteli,et al. Functional architecture in the cell nucleus. , 2001, The Biochemical journal.
[51] A. Levine,et al. Human TAFII31 protein is a transcriptional coactivator of the p53 protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[52] Hyunggee Kim,et al. The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells , 2001, Oncogene.
[53] A. Levine,et al. The mdm-2 gene is induced in response to UV light in a p53-dependent manner. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[54] Tom Misteli,et al. Functional architecture in the cell nucleus. , 2001 .
[55] A. Levine,et al. p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback. , 2005, Systems biology.
[56] Mengjia Tang,et al. Hdmx Modulates the Outcome of P53 Activation in Human Tumor Cells* , 2006, Journal of Biological Chemistry.
[57] W. Deppert,et al. Cell-specific transcriptional activation of the mdm2-gene by ectopically expressed wild-type form of a temperature-sensitive mutant p53. , 1995, Oncogene.
[58] C. Maki. Oligomerization Is Required for p53 to be Efficiently Ubiquitinated by MDM2* , 1999, The Journal of Biological Chemistry.
[59] Baoli Hu,et al. MDMX Overexpression Prevents p53 Activation by the MDM2 Inhibitor Nutlin* , 2006, Journal of Biological Chemistry.
[60] A. Gronenborn,et al. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. , 1994, Science.
[61] M. E. Perry,et al. The p53 Tumor Suppressor Protein Does Not Regulate Expression of Its Own Inhibitor, MDM2, Except under Conditions of Stress , 2000, Molecular and Cellular Biology.
[62] H. Kawai,et al. Mutual Dependence of MDM 2 and MDMX in Their Functional Inactivation of p 53 * , 2002 .
[63] G. Wahl,et al. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas , 2006, Nature Reviews Cancer.
[64] Patrick W. Lee,et al. Biogenesis of p53 Involves Cotranslational Dimerization of Monomers and Posttranslational Dimerization of Dimers , 2002, The Journal of Biological Chemistry.
[65] U Alon,et al. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[66] C. Arrowsmith,et al. Solution structure of the tetrameric minimum transforming domain of p53 , 1995, Nature Structural Biology.
[67] J. C. Schmitz,et al. Regulation of p53 Expression in Response to 5-Fluorouracil in Human Cancer RKO Cells , 2007, Clinical Cancer Research.
[68] Uri Alon,et al. Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.
[69] Jelena Kovacevic,et al. Wavelets and Subband Coding , 2013, Prentice Hall Signal Processing Series.
[70] Mihee M. Kim,et al. RING domain-mediated interaction is a requirement for MDM2's E3 ligase activity. , 2007, Cancer research.
[71] A. Fersht,et al. Cooperative binding of tetrameric p53 to DNA. , 2004, Journal of molecular biology.
[72] A. Levine,et al. Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain , 1996, Science.
[73] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[74] A. Ciechanover,et al. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[75] B. Vojtesek,et al. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers. , 1999, The Biochemical journal.
[76] A. Fersht,et al. Comparative binding of p53 to its promoter and DNA recognition elements. , 2005, Journal of molecular biology.
[77] Valerie Reinke,et al. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53 , 2001, Nature Genetics.
[78] George I. Mihalas,et al. POSSIBLE OSCILLATORY BEHAVIOR IN P53–MDM2 INTERACTION COMPUTER SIMULATION , 2000 .
[79] S. Letteboer,et al. Hdmx Protein Stability Is Regulated by the Ubiquitin Ligase Activity of Mdm2* , 2003, Journal of Biological Chemistry.
[80] D. George,et al. Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein* , 1999, The Journal of Biological Chemistry.
[81] R. Aebersold,et al. Gene Expression Analyzed by High-resolution State Array Analysis and Quantitative Proteomics , 2004, Molecular & Cellular Proteomics.
[82] H. Ovaa,et al. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. , 2005, Molecular cell.
[83] Xiaodong Cai,et al. Exact stochastic simulation of coupled chemical reactions with delays. , 2007, The Journal of chemical physics.
[84] R. Copeland,et al. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination. , 2006, Biochemistry.
[85] P. Hainaut,et al. 25 years of p53 research , 2005 .
[86] A. Telser. Molecular Biology of the Cell, 4th Edition , 2002 .
[87] G. Wahl,et al. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4 , 2006, Cell Death and Differentiation.
[88] T. Elston,et al. Stochasticity in gene expression: from theories to phenotypes , 2005, Nature Reviews Genetics.
[89] M. Oren,et al. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. , 1993, Oncogene.
[90] L. Vassilev,et al. In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.
[91] A. Giaccia,et al. The complexity of p53 modulation: emerging patterns from divergent signals. , 1998, Genes & development.
[92] N. Monk. Oscillatory Expression of Hes1, p53, and NF-κB Driven by Transcriptional Time Delays , 2003, Current Biology.
[93] M. Kubbutat,et al. Regulation of Mdm2-Directed Degradation by the C Terminus of p53 , 1998, Molecular and Cellular Biology.
[94] Lawrence A. Donehower,et al. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.
[95] M. Magnasco,et al. Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes. , 2003, Genome research.
[96] M. Gorospe,et al. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation , 2003, Proceedings of the National Academy of Sciences of the United States of America.